Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry, Researchers, Patient Groups, and FDA Staff on Meetings With the Office of Orphan Products Development

Özet

The Food and Drug Administration (FDA) is announcing that a collection of information entitled, "Guidance for Industry, Researchers, Patient Groups, and FDA Staff on Meetings with the Office of Orphan Products Development" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.